Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,151 | 2,631 | 13,021 | 2,614 | 1,747 |
| Marketable Securities | 87,954 | 12,871 | 5,976 | 6,344 | 7,408 |
| Receivables | 368 | 365 | 155 | 171 | 266 |
| TOTAL | $94,473 | $15,867 | $19,152 | $9,129 | $9,421 |
| Non-Current Assets | |||||
| PPE Net | 374 | 433 | 491 | 548 | 606 |
| TOTAL | $374 | $433 | $491 | $548 | $606 |
| Total Assets | $94,847 | $16,300 | $19,643 | $9,677 | $10,027 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,804 | 2,428 | 3,310 | 2,184 | 2,550 |
| TOTAL | $3,804 | $2,698 | $3,848 | $2,995 | $3,635 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 270 | 538 | 811 | 1,085 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 150 | 150 |
| TOTAL | $N/A | $N/A | $N/A | $150 | $150 |
| Total Liabilities | $3,804 | $2,698 | $3,848 | $3,145 | $3,785 |
| Shareholders' Equity | |||||
| Common Shares | 58 | 40 | 40 | 36 | 34 |
| Retained earnings | -81,810 | -79,125 | -76,619 | -72,975 | -70,174 |
| Other shareholders' equity | -29 | -36 | -7 | -8 | -20 |
| TOTAL | $91,043 | $13,602 | $15,795 | $6,532 | $6,242 |
| Total Liabilities And Equity | $94,847 | $16,300 | $19,643 | $9,677 | $10,027 |